TearLab Corp - Strategic SWOT Analysis Review
![](/report_cover/1896/tearlab-corp-strategic-swot-analysis-review_en.gif)
TearLab Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
TearLab Corp (TearLab) is an in-vitro diagnostic company which focuses on ophthalmic devices. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship product TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. TearLab conducts research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. It sells products directly in the US. The company also sells products through distributors in Europe, Canada, Australia, Central and South America, and Asia. TearLab is headquartered in Escondido, California, the US.
TearLab Corp Key Recent Developments
Jul 28,2020: TearLab appoints Adam Szaronos as Chief Commercial Officer
Mar 05,2020: TearLab reports fourth quarter and full year 2019 financial results
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
TearLab Corp (TearLab) is an in-vitro diagnostic company which focuses on ophthalmic devices. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship product TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. TearLab conducts research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. It sells products directly in the US. The company also sells products through distributors in Europe, Canada, Australia, Central and South America, and Asia. TearLab is headquartered in Escondido, California, the US.
TearLab Corp Key Recent Developments
Jul 28,2020: TearLab appoints Adam Szaronos as Chief Commercial Officer
Mar 05,2020: TearLab reports fourth quarter and full year 2019 financial results
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
TearLab Corp - Key Facts
TearLab Corp - Key Employees
TearLab Corp - Key Employee Biographies
TearLab Corp - Major Products and Services
TearLab Corp - History
TearLab Corp - Company Statement
TearLab Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
TearLab Corp - Business Description
TearLab Corp - SWOT Analysis
SWOT Analysis - Overview
TearLab Corp - Strengths
TearLab Corp - Weaknesses
TearLab Corp - Opportunities
TearLab Corp - Threats
TearLab Corp - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
TearLab Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
TearLab Corp, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Jul 28, 2020: TearLab appoints Adam Szaronos as Chief Commercial Officer
Mar 05, 2020: TearLab reports fourth quarter and full year 2019 financial results
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
TearLab Corp - Key Facts
TearLab Corp - Key Employees
TearLab Corp - Key Employee Biographies
TearLab Corp - Major Products and Services
TearLab Corp - History
TearLab Corp - Company Statement
TearLab Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
TearLab Corp - Business Description
TearLab Corp - SWOT Analysis
SWOT Analysis - Overview
TearLab Corp - Strengths
TearLab Corp - Weaknesses
TearLab Corp - Opportunities
TearLab Corp - Threats
TearLab Corp - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
TearLab Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
TearLab Corp, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Jul 28, 2020: TearLab appoints Adam Szaronos as Chief Commercial Officer
Mar 05, 2020: TearLab reports fourth quarter and full year 2019 financial results
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
TearLab Corp, Key Facts
TearLab Corp, Key Employees
TearLab Corp, Key Employee Biographies
TearLab Corp, Major Products and Services
TearLab Corp, History
TearLab Corp, Subsidiaries
TearLab Corp, Key Competitors
TearLab Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
TearLab Corp, Recent Deals Summary
TearLab Corp, Key Facts
TearLab Corp, Key Employees
TearLab Corp, Key Employee Biographies
TearLab Corp, Major Products and Services
TearLab Corp, History
TearLab Corp, Subsidiaries
TearLab Corp, Key Competitors
TearLab Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
TearLab Corp, Recent Deals Summary
LIST OF FIGURES
TearLab Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
TearLab Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021